| Healthcare and Medical Technology |
1 |
1 |
| Vagina |
0 |
0.99 |
| Skin and Soft Tissue Infection |
0 |
0.93 |
| Microbiome |
0 |
0.58 |
| Fungal Infection |
0 |
0.39 |
| Vaginal Candidiasis |
0 |
0.33 |
| Candidiasis |
0 |
0.29 |
| Bacterial Vaginosis |
0 |
0.26 |
| Human Papillomavirus |
0 |
0.26 |
| HIV Infection |
0 |
0.23 |
| Endometriosis |
0 |
0.19 |
| Pregnancy |
0 |
0.19 |
| Cervix |
0 |
0.17 |
| Revenue and Practice Management |
0 |
0.17 |
| Cervical Cancer |
0 |
0.14 |
| Child |
0 |
0.13 |
| Chlamydial Infection |
0 |
0.13 |
| Reproductive Health |
0 |
0.13 |
| Tissue |
0 |
0.13 |
| Antibiotics |
0 |
0.1 |
| Complementary and Alternative Medicine |
0 |
0.1 |
| Vaccines |
0 |
0.1 |
| Uterus |
0 |
0.09 |
| Blood Vessel |
0 |
0.06 |
| Bone Marrow |
0 |
0.06 |
| Premature Birth |
0 |
0.06 |
| Birth |
0 |
0.04 |
| Blood |
0 |
0.04 |
| Bone |
0 |
0.04 |
| Cancer |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Imbalance |
0 |
0.04 |
| Infertility |
0 |
0.04 |
| Kidney |
0 |
0.04 |
| Lung |
0 |
0.04 |
| Massachusetts |
0 |
0.04 |
| Newborn |
0 |
0.04 |
| Physiology |
0 |
0.04 |
| Probiotics |
0 |
0.04 |
| Reproductive Medicine |
0 |
0.04 |
| Salary and Compensation |
0 |
0.04 |
| Viral Infection |
0 |
0.04 |